Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016)

Amarin Corp Plc\Uk (AMRN) posted quarterly Current Deferred Tax Assets of $900000.0 for Q4 2016, up 200.0% year-over-year from $300000.0 in Q1 2016, and up 200.0% quarter-over-quarter from -$900000.0 in Q4 2015.

Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Current Deferred Tax Assets for 7 consecutive years, with $900000.0 the latest figure, recorded in Q4 2016.

  • In Q4 2016, Current Deferred Tax Assets rose 200.0% year-over-year to $900000.0; the TTM figure through Dec 2016 stood at $900000.0 (up 200.0% YoY), while the FY2016 annual figure was $900000.0, up 200.0% from the prior year.
  • Current Deferred Tax Assets climbed to $900000.0 in Q4 2016 per AMRN's latest filing, from -$900000.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $937000.0 in Q4 2012 and bottomed at -$900000.0 in Q4 2015.
  • Historically, Current Deferred Tax Assets has averaged $645000.0 across 5 years, with a median of $900000.0 in 2016.
  • Annual changes were most pronounced in 2015 — Current Deferred Tax Assets slumped 196.36% — and 2016, when it jumped 200.0%.
  • Amarin Corp Plc\Uk's Current Deferred Tax Assets stood at $937000.0 in 2012, then slumped by 49.73% to $471000.0 in 2013, then soared by 98.3% to $934000.0 in 2014, then plunged by 196.36% to -$900000.0 in 2015, then surged by 200.0% to $900000.0 in 2016.
  • Business Quant data shows AMRN's Current Deferred Tax Assets at $900000.0 in Q4 2016, -$900000.0 in Q4 2015, and $934000.0 in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2016 900,000.00
Dec 31, 2016 900,000.00
Dec 31, 2015 -900,000.00
Dec 31, 2015 -900,000.00
Sep 30, 2015 934,000.00
Sep 30, 2015 934,000.00
Jun 30, 2015 934,000.00
Jun 30, 2015 934,000.00
Mar 31, 2015 934,000.00
Mar 31, 2015 934,000.00
Dec 31, 2014 934,000.00
Dec 31, 2014 934,000.00
Sep 30, 2014 471,000.00
Sep 30, 2014 471,000.00
Jun 30, 2014 471,000.00
Jun 30, 2014 471,000.00
Mar 31, 2014 471,000.00
Mar 31, 2014 471,000.00
Dec 31, 2013 471,000.00
Dec 31, 2013 471,000.00